^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Retinoblastoma
    Drug:cyclophosphamide (Alkylating agent)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    Source:
    FDA
    Published date:
    10/25/2014
    Excerpt:
    Cyclophosphamide is an alkylating drug indicated for treatment of:…retinoblastoma…